S&P 500   2,995.68 (+1.00%)
DOW   27,024.80 (+0.89%)
QQQ   193.52 (+1.27%)
AAPL   235.32 (-0.23%)
FB   188.89 (+3.06%)
MSFT   141.58 (+1.45%)
GOOGL   1,242.24 (+2.01%)
AMZN   1,767.38 (+1.78%)
CGC   20.10 (+6.57%)
NVDA   196.37 (+5.28%)
MU   46.46 (+3.54%)
BABA   175.29 (+2.41%)
GE   8.89 (+1.95%)
TSLA   257.89 (+0.36%)
AMD   30.72 (+0.62%)
T   37.90 (+1.15%)
F   9.07 (+2.83%)
ACB   3.76 (+7.12%)
PRI   123.67 (+1.81%)
NFLX   284.25 (-0.45%)
BAC   29.73 (+2.02%)
GILD   65.30 (+1.22%)
DIS   129.76 (+0.05%)
S&P 500   2,995.68 (+1.00%)
DOW   27,024.80 (+0.89%)
QQQ   193.52 (+1.27%)
AAPL   235.32 (-0.23%)
FB   188.89 (+3.06%)
MSFT   141.58 (+1.45%)
GOOGL   1,242.24 (+2.01%)
AMZN   1,767.38 (+1.78%)
CGC   20.10 (+6.57%)
NVDA   196.37 (+5.28%)
MU   46.46 (+3.54%)
BABA   175.29 (+2.41%)
GE   8.89 (+1.95%)
TSLA   257.89 (+0.36%)
AMD   30.72 (+0.62%)
T   37.90 (+1.15%)
F   9.07 (+2.83%)
ACB   3.76 (+7.12%)
PRI   123.67 (+1.81%)
NFLX   284.25 (-0.45%)
BAC   29.73 (+2.02%)
GILD   65.30 (+1.22%)
DIS   129.76 (+0.05%)
Log in

Petmed Express Stock Price, News & Analysis (NASDAQ:PETS)

$18.73
+0.17 (+0.92 %)
(As of 10/15/2019 04:00 PM ET)
Today's Range
$18.56
Now: $18.73
$19.15
50-Day Range
$15.41
MA: $17.40
$19.06
52-Week Range
$15.00
Now: $18.73
$33.28
Volume476,160 shs
Average Volume713,649 shs
Market Capitalization$377.88 million
P/E Ratio12.70
Dividend Yield5.82%
Beta0.57
PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes. Read More…

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryInternet Retail
SectorRetail/Wholesale
Current SymbolNASDAQ:PETS
CUSIP71638210
Phone561-526-4444

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$283.42 million
Cash Flow$1.93 per share
Book Value$6.51 per share

Profitability

Net Income$37.74 million

Miscellaneous

Employees187
Market Cap$377.88 million
Next Earnings Date10/28/2019 (Estimated)
OptionableOptionable

Receive PETS News and Ratings via Email

Sign-up to receive the latest news and ratings for PETS and its competitors with MarketBeat's FREE daily newsletter.


Petmed Express (NASDAQ:PETS) Frequently Asked Questions

What is Petmed Express' stock symbol?

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

How often does Petmed Express pay dividends? What is the dividend yield for Petmed Express?

Petmed Express declared a quarterly dividend on Monday, July 22nd. Investors of record on Friday, August 2nd will be given a dividend of $0.27 per share on Friday, August 9th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 5.77%. The ex-dividend date is Thursday, August 1st. View Petmed Express' Dividend History.

How were Petmed Express' earnings last quarter?

Petmed Express Inc (NASDAQ:PETS) issued its earnings results on Monday, July, 22nd. The company reported $0.26 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.42 by $0.16. The firm had revenue of $79.99 million for the quarter, compared to the consensus estimate of $85.83 million. Petmed Express had a net margin of 11.05% and a return on equity of 23.42%. The company's revenue for the quarter was down 8.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.62 earnings per share. View Petmed Express' Earnings History.

When is Petmed Express' next earnings date?

Petmed Express is scheduled to release their next quarterly earnings announcement on Monday, October 28th 2019. View Earnings Estimates for Petmed Express.

What price target have analysts set for PETS?

1 analysts have issued 12-month price objectives for Petmed Express' stock. Their predictions range from $15.00 to $15.00. On average, they anticipate Petmed Express' share price to reach $15.00 in the next year. This suggests that the stock has a possible downside of 19.9%. View Analyst Price Targets for Petmed Express.

What is the consensus analysts' recommendation for Petmed Express?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Petmed Express.

Has Petmed Express been receiving favorable news coverage?

Media coverage about PETS stock has trended extremely negative on Tuesday, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Petmed Express earned a media sentiment score of -4.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Petmed Express.

Are investors shorting Petmed Express?

Petmed Express saw a decrease in short interest in the month of September. As of September 15th, there was short interest totalling 8,640,000 shares, a decrease of 6.7% from the August 15th total of 9,260,000 shares. Based on an average trading volume of 860,300 shares, the short-interest ratio is currently 10.0 days. Currently, 44.8% of the company's shares are short sold. View Petmed Express' Current Options Chain.

Who are some of Petmed Express' key competitors?

What other stocks do shareholders of Petmed Express own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Petmed Express investors own include Intel (INTC), Alibaba Group (BABA), AT&T (T), NVIDIA (NVDA), Netflix (NFLX), Micron Technology (MU), Ford Motor (F), Advanced Micro Devices (AMD), Gilead Sciences (GILD) and Cisco Systems (CSCO).

Who are Petmed Express' key executives?

Petmed Express' management team includes the folowing people:
  • Mr. Menderes Akdag, CEO, Pres & Director (Age 58)
  • Mr. Bruce S. Rosenbloom, CFO & Treasurer (Age 50)
  • Ms. Alison Berges, Corp. Sec. & Gen. Counsel

Who are Petmed Express' major shareholders?

Petmed Express' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Rothschild Investment Corp IL (0.96%), Scout Investments Inc. (0.61%), North Star Investment Management Corp. (0.52%), Menlo Advisors LLC (0.43%), State of Alaska Department of Revenue (0.08%) and Fox Run Management L.L.C. (0.07%). Company insiders that own Petmed Express stock include Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Institutional Ownership Trends for Petmed Express.

Which major investors are selling Petmed Express stock?

PETS stock was sold by a variety of institutional investors in the last quarter, including North Star Investment Management Corp., Scout Investments Inc., Pacer Advisors Inc. and Menlo Advisors LLC. View Insider Buying and Selling for Petmed Express.

Which major investors are buying Petmed Express stock?

PETS stock was purchased by a variety of institutional investors in the last quarter, including Fox Run Management L.L.C., Rothschild Investment Corp IL and State of Alaska Department of Revenue. View Insider Buying and Selling for Petmed Express.

How do I buy shares of Petmed Express?

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Petmed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $18.73.

How big of a company is Petmed Express?

Petmed Express has a market capitalization of $377.88 million and generates $283.42 million in revenue each year. Petmed Express employs 187 workers across the globe.View Additional Information About Petmed Express.

What is Petmed Express' official website?

The official website for Petmed Express is http://www.1800petmeds.com/.

How can I contact Petmed Express?

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.


MarketBeat Community Rating for Petmed Express (NASDAQ PETS)

Community Ranking:  1.5 out of 5 (star half star)
Outperform Votes:  168 (Vote Outperform)
Underperform Votes:  407 (Vote Underperform)
Total Votes:  575
MarketBeat's community ratings are surveys of what our community members think about Petmed Express and other stocks. Vote "Outperform" if you believe PETS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Featured Article: Dividend Yield

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel